En vivo
Endpoints NewsAngelini fortifies neurology portfolio with $4.1B buyout of Catalyst PharmaSiemens HealthineersWeak Diagnostics segment weighs heavily on Siemens Healthineers - marketscreener.comLabiotechMaking labs smarter for scientific breakthroughsSiemens HealthineersEarnings call transcript: Siemens Healthineers Q2 2026 sees stock plunge amid Diagnostics woes - Investing.comScience Daily BiotechScientists accidentally discover DNA that breaks the rules of lifeSiemens HealthineersSiemens Healthineers Cuts 2026 Outlook As China Diagnostics Resets - Finimize10x Genomics BlogUS-based 10x Genomics establishes first dedicated R&D lab in Singapore - BioSpectrum AsiaPfizerPowered by Purpose: Celebrating Clinical Trials Day 2025 - PfizerMedtronicMedtronic's bid for US-based medical device company reviewed in Australia - MLexeLifeHow membranes shape up for lipid transferClinical OMICsProtein Biomarkers in Practice: Strategies to Reduce Drug Development RiskSiemens HealthineersSiemens Healthineers’ CDC Test Renewal And What It Means For Valuation - Yahoo Finance

Archivo

Reciente Más antiguo Borrar
Total 403
Página 10 / 23
Búsqueda --